Ocehepa 3g chemical powder to treat liver dysfunction (14 packs x 5g)

Dosage form Box of 14 packs x 5g
Specifications L-Ornithine-L-ASPARTATE

Ingredient

Thành phần cho 5g

Composition informationContent
L-Ornithine-L-ASPARTATE3000mg

Uses

indications

Ocehepa drug is indicated in the following cases:

Treatment of cases of liver dysfunction, acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis. Especially in the treatment of blood ammonia syndrome, the first stage of cognitive disorders (money) or neurological complications (liver - brain coma).

Pharmacokology

L - Ornithin L - Aspartat is the durable salt of two amino acid L - Ornithin and L - Aspartic acid, L - L - Ornithin L - Aspartat stimulating the production of uric acid in the liver and stimulating glutamine production to minimize ammonia, playing an important role in Ammonia detox Disoxify in the liver, improve energy balance. When taken and absorbed into the body, L - Ornithin L - Aspartat separated forming L - Ornithin and L - Aspartat are two important amino acids involved in the urea metabolic cycle in the liver.

Aspartat and Ornithin are the substrates for glutamat synthesis in damaged liver cells. The inverse of the amino, including the transportation of amino groups from most amino acids - Ketoglutarat, resulting in glutamat and finally glutamine, a non -toxic compound. This is the main substance formed in central nervous system cells and muscle cells, intracellular glutamin is a substance that regulates the synthesis of protein and when the amount of glutamine increases, the protein synthesis will increase.

Aspartat is involved in citric acid ring and catalyzes the above reactions that occur easily to protect other amino acids and separated amino acids. The amino glutamat group participates in the synthesis of carbamoylphosphate thanks to carbamylphosphate synthese. The transfer of carbamoyl groups to ornithin in the urea led to the formation of citrullin and finally urea. In the Glutamat - Glutamine system, there is an accumulation of 1/4 of ammonia content created during the transformation. The above reactions occur in the presence of Ornithin carbamoyltransferase. Ornithin is an active substance of carbamoylphosphate synthese and carbamoyltransferase.

Aspartat is involved in the synthesis of pyrimidine to help regenerate nucleic acid in damaged liver cells.

Therefore, the combination of L - Ornithin and L - aspartat has a similar effect in the process of reducing the concentration of ammonia (blood ammonia produced by protein decomposition, liver is responsible for turning blood ammonia into urea). In addition, Ornithin and aspartat indirectly participate in creating ATP energy to provide energy for urea synthesis processes and stimulate the activity of other liver functions. Especially the function of fat metabolism and liver parenchyma regeneration.

pharmacokinetics

l - Ornithin - L - Aspartat is well absorbed through the digestive tract. Short waste sale time 0.3 - 0.4 hours, small part of Aspartat is excreted through urine.

Before taking Ocehepa 3g chemical powder to treat liver dysfunction (14 packs x 5g)

How to use

Mix the drug pack into an appropriate amount of water, drink in meals. Do not mix medicine into milk, fruit juice.

Dosage

Unless there are other indications, the usual dose 1-2 packs/time x 3 times/day.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?

No report.

What to do when forgetting 1 dose?

Side Effects

When using Ocehepa drug you may experience unwanted effects (ADR).

Uncommon, 1/1000

  • Nausea, vomiting, stomach pain, flatulence, diarrhea.

    • Very rare, ADR

  • Pain in the lower limb.

    • These unwanted effects are often transient and do not need to stop.

    Instructions on how to handle ADR

    When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Ocehepa drugs contraindicated in the following cases:

  • Cases of sensitivity to L - Ornithin - L - Aspartat or any ingredient of the drug.

    • Severe kidney failure.

  • In case the amount of creatinine in the serum exceeds 3 mg/100 ml should be very careful when used.
  • Not used in cases of non -tolerance fructose or sensitivity to any ingredient of the drug.
  • Do not take medicine for children.

    • Be cautious when using

    If the drug does not see if there is a good progress, when an unpleasant symptom occurs or has unwanted effects, it should be stopped and consulted with a physician. This drug contains an amount of aspartam, so it is cautious for people with phenylcetonurie (phenylceton - urinary)

    The ability to drive and operate machinery

    The drug does not cause drowsiness does not affect the operation of the person when driving or operating machinery.

    Pregnancy

    The drug is only for pregnant women when they are really necessary according to the instructions of the physician.

    The period of breastfeeding

    The drug is only for breastfeeding women when really necessary as directed by the physician.

    Drug interaction

    No report.

    Storage

    In a dry place, temperatures below 30 ° C.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords